This content is machine translated Hemophilia A and B Personalized approach and innovative treatment options Severe haemophilia carries a high risk of life-threatening complications if left untreated. In addition to the classic therapeutic principle of substituting the missing coagulation factor, new treatment options have been...…
View Post 6 min This content is machine translated EHA 2025 Progress in multiple myeloma The annual meeting of the European Hematology Association (EHA) has been one of the most important focal points for international haematology for many years. With more than 15,000 participants on...…
View Post 7 min This content is machine translated Management of patients after alloHCST ERS/EBMT guideline recommendations on pulmonary cGvHD After an allogeneic stem cell transplant (alloHCST), life-threatening chronic graft-versus-host disease (cGvHD) occurs again and again. This is when the donor’s immune cells attack the recipient’s body. Lung involvement in...…
View Post 4 min This content is machine translated Case series Bleeding prophylaxis for von Willebrand disease Von Willebrand’s disease is predominantly inherited in an autosomal dominant manner and is the most common hereditary cause of a bleeding tendency. It is caused by a quantitative and/or qualitative...…
View Post 5 min This content is machine translated Acute leukemia: Disease management Priorities from the perspective of patients and family caregivers Studies launched by the patient organization ALAN (The Acute Leukemia Advocates Network) map patient preferences in acute leukemia on the one hand and record the situation of relatives involved in...…
View Post 6 min This content is machine translated Update on diagnostics, risk stratification and therapy Acute myeloid leukemia 2025 Acute myeloid leukemia (AML) remains one of the greatest challenges in hematology. Despite established chemotherapy protocols, the prognosis for many patients remains unfavorable. In recent years, however, new molecular classifications,...…
View Post 16 min This content is machine translated Blastic plasmacytoid dendritic cell neoplasia Rare malignancy from a dermatological perspective Blastic plasmacytoid dendritic cell neoplasia (BPDCN) is an aggressive hematologic malignancy originating from immature plasmacytoid dendritic cell (PDC) precursors. The initial manifestation of BPDCN often consists of cutaneous lesions. In...… CME-Test
View Post 5 min This content is machine translated Paroxysmal nocturnal hemoglobinuria Real-world data on thrombosis predictors and C5 complement inhibitors Paroxysmal nocturnal haemoglobinuria (PNH) is a rare, acquired disease of haematopoietic stem cells of the bone marrow. GPI deficiency results in the absence of complement-regulating proteins. Thromboembolic complications are the...…
View Post 4 min This content is machine translated Current findings on myelofibrosis Reduce anemia and transfusion dependency Myelofibrosis (MF) is a rare clonal disease of pluripotent hematopoietic stem and progenitor cells. There have been significant advances in the treatment options for MF in recent years, but anemia...…
View Post 10 min This content is machine translated Electrolyte disturbance Hyponatremia in the outpatient setting Over the last two decades, the evidence has become increasingly clear that even relatively mild hyponatremia without obvious or severe symptoms is clinically relevant. It leads to neurocognitive impairments, gait...… CME-Test
View Post 8 min This content is machine translated ASCO 2025 Supportive therapies for greater adherence and compliance ASCO 2025 is the annual meeting of the American Society of Clinical Oncology (ASCO), which took place in Chicago from May 30 to June 3. In this section, we take...…
